VanEck Global Healthcare Leaders ETF
VanEck · Nasdaq Global Healthcare Index · Since 2020
Annual fee
0.57%
$57/year per $10,000
Fund size
$49M
AUD
Dividend yield
0.6%
Annually · approx. as at Q2 2026
Holdings
50
companies
Dividend yield is a trailing distribution figure. Past performance is not a reliable indicator of future returns.
Next estimated distribution: ~December 2026 (estimated, not guaranteed; confirm with the fund manager). Distribution calendar →
HLTH is the unhedged sibling of CURE, giving you the same global healthcare exposure but with currency movements included. When the AUD falls, HLTH benefits in AUD terms alongside the underlying healthcare stock performance. Healthcare is a relatively defensive sector, demand for medicines and healthcare services is less sensitive to economic cycles than consumer discretionary spending.
Based on publicly available fund data. Not a recommendation to buy or sell.
Strengths
Watch out for
| Company | Weight |
|---|---|
| Arrowhead Pharmaceuticals Inc. | 2.7% |
| West Pharmaceutical Services Inc. | 2.7% |
| Alk-Abello A/S | 2.5% |
| Illumina Inc. | 2.4% |
| Exelixis Inc. | 2.4% |
| Neurocrine Biosciences Inc. | 2.4% |
| Ypsomed Holding Ag | 2.3% |
| Teva Pharmaceutical Industries Limited | 2.3% |
| Argenx Se | 2.3% |
| Novo Nordisk A/S | 2.3% |
See how HLTH combines with your other ETFs: Stock X-Ray →
| Sector | Weight |
|---|---|
| Health Care | 100% |
| Country | Weight |
|---|---|
| United States | 61.5% |
| Japan | 11.1% |
| South Korea | 6% |
| Denmark | 4.1% |
| Switzerland | 4% |
| United Kingdom | 3.3% |
| Other / cash | 10% |
Historical returns
Past performance is not a reliable indicator of future returns.
Data as at Q2 2026. Past performance is not a reliable indicator of future returns. Figures are approximate total returns in AUD including distributions. Source: fund manager fact sheets.
Compare HLTH with similar ETFs
Side-by-side fees, holdings overlap and performance.
Find near-twins of HLTH →General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
HLTH is the unhedged sibling of CURE, giving you the same global healthcare exposure but with currency movements included.
HLTH's annual management fee is 0.57% p.a. ($57 per $10,000 invested).
HLTH pays distributions annually. Distributions are not guaranteed and will vary.